A new impedimetric biosensor utilizing VEGF receptor-1 (Flt-1): Early diagnosis of vascular endothelial growth factor in breast cancer
- 15 June 2011
- journal article
- research article
- Published by Elsevier BV in Biosensors and Bioelectronics
- Vol. 26 (10), 4032-4039
- https://doi.org/10.1016/j.bios.2011.03.025
Abstract
No abstract availableThis publication has 26 references indexed in Scilit:
- Exploring a cancer biomarker: the example of C-reactive protein.JNCI Journal of the National Cancer Institute, 2010
- A review of AC impedance modeling and validation in SOFC diagnosisElectrochimica Acta, 2007
- Electrochemical evaluation of avidin–biotin interaction on self-assembled gold electrodesElectrochimica Acta, 2005
- Impedimetric biosensorsJournal of Bioscience and Bioengineering, 2004
- Probing Biomolecular Interactions at Conductive and Semiconductive Surfaces by Impedance Spectroscopy: Routes to Impedimetric Immunosensors, DNA‐Sensors, and Enzyme BiosensorsElectroanalysis, 2003
- Apoptosis in Breast CarcinomaPathology - Research and Practice, 2000
- Alternative Splicing of Vascular Endothelial Growth Factor (VEGF)-R1 (FLT-1) pre-mRNA Is Important for the Regulation of VEGF ActivityMolecular Endocrinology, 1999
- A Linear Kronig‐Kramers Transform Test for Immittance Data ValidationJournal of the Electrochemical Society, 1995
- Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor.Proceedings of the National Academy of Sciences of the United States of America, 1993
- Purification of a glycoprotein vascular endothelial cell mitogen from a rat glioma-derived cell line.Proceedings of the National Academy of Sciences of the United States of America, 1990